The 16th Mexico-Japan Endoscopy Conference
Program |
Mailing List |
Connection Information |
Files |
Report |
ver 1.75
* For more information, please refer to the TEMDEC policy.
The 16th Mexico-Japan Endoscopy Conference
Key Members
Chair | Miguel Tanimoto | The National Institute of Medical Sciences and Nutrition | MX |
Co-Chair 1 | - | - | - |
Co-Chair 2 | - | - | - |
Chief Engineer 1 | Shunta Tomimatsu | Kyushu University Hospital | JP |
Chief Engineer 2 | Mayuko Okada | Kyushu University Hospital | JP |
Chief Engineer 3 | Eyitayo Adeniyi Adebayo | Rome Business School | IT |
Chief Engineer 4 | - | - | - |
Connecting Institutions
Red is to be decidedCity, Country | Institution | Moderator | Local Engineer | |
---|---|---|---|---|
1(Main). | Mexico City, MX | The National Institute of Medical Sciences and Nutrition | Miguel Tanimoto | Nancy Gertrudiz |
2. | Fukuoka, JP | Kyushu University Hospital | Tomohiko Moriyama | Shunta Tomimatsu |
Schedule
Main venue | Localtime | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.Mexico City, MX (UTC-06:00) | Contents | Presenter | UTC+09:00 (Institution No. 2) | |||||||||||||||||||
2018.12.11 17:30 - 18:00 | 2018.12.12 08:30 - 09:00 | |||||||||||||||||||||
18:00 - 18:10 | Opening remarks and greetings | Miguel Tanimoto(The National Institute of Medical Sciences and Nutrition) | 09:00 - 09:10 | |||||||||||||||||||
18:10 - 18:50 | Clinical characteristics of gastric cancer discovered after H. pylori eradication | Tomohiko Moriyama(Kyushu University Hospital) | 09:10 - 09:50 | |||||||||||||||||||
18:50 - 19:00 | Closing remarks | Miguel Tanimoto(The National Institute of Medical Sciences and Nutrition) | 09:50 - 10:00 |
Precautions
- The conference will be recorded by the photos and movies.
- Pictures taken at the conference will be published in TEMDEC home page, annual report and conference presentations.
- Do not present the personal information of patients any in oral and presentation materials without obtaining the patient's consent.
* For more information, please refer to the TEMDEC policy.